Medical, Pharmaceutical, and Formulary Policy Updates
Published October 2026
Below is a recap of the Medical Policies that went into effect recently. All policies are reviewed at least once annually. For more detailed information on these changes, please visit here.
Effective August 1, 2026
Effective October 1, 2026
Below is a recap of the Pharmacy Policies that went into effect recently. All policies are reviewed at least once annually. For more detailed information on these changes, please review our Provider FastFax Library or visit all policies here.
Below is a list of medications recently reviewed by the MVP Pharmacy and Therapeutics Committee. For coverage information regarding these medications, please review the MVP Formularies available at here. For more detailed information regarding pharmacy changes, please review Provider FastFax Library or visit all policies MVP Health Care Medical Policy.
A list of formulary changes for Plan Year 2026 is available for review: 2026 Commercial and Marketplace Formulary Changes. Changes will take effect on the member’s pharmacy “Plan Year” start date.
Drugs removed from prior authorization for commercial, marketplace and self-funded formularies
|
Enbumyst™ (bumetanide nasal spray) |
|
Enbumyst™ (bumetanide nasal spray) |
|
Inluriyo™ (Imlunestrant) |
|
Javadin™ (clonidine hydrochloride) |
|
Komzifti™ (ziftomenib) |
|
Omlonti®(omidenepag isopropyl) |
|
Omlonti®(omidenepag isopropyl) |
|
Saphnelo® pen (anifrolumab-fnia) |
|
Subvenite® suspension (lamotrigine) |
New drugs excluded for commercial, marketplace and self-funded formularies
|
Cardamyst™ (etripamil) |
|
Exdensur® (depemokimab-ulaa) |
|
Jascayd® (nerandomilast) |
|
Palsonify™ (paltusotine) |
|
Rhapsido® (remibrutinib) |
|
Tonmya™ (cyclobenzaprine) |
|
Vyscoxa™ (celecoxib) |
New generics that recently came to market
|
Brand Name |
Generic Name |
|---|---|
|
Astagraf XL |
Tacrolimus ER capsule |
|
Janumet |
Sitagliptin-metformin |
|
Januvia |
Sitagliptin |
|
Xeljanz solution 1mg/ml |
Tofacitinib solution 1mg/ml |
|
Xeljanz tablet |
Tofacitinib tablet |
|
Xeljanz XR tablet |
Tofacitanib ER tablet |